Literature DB >> 6166801

Feline hypoxic pulmonary vasoconstriction is not blocked by the angiotensin I-converting enzyme inhibitor, captopril.

R L Prewitt, C W Leffler.   

Abstract

Because of evidence that angiotensin II may be necessary for pulmonary hypoxic vasoconstriction, we investigated the response to 3% oxygen breathing before and after the blockade of angiotensin I-converting enzyme with captopril. The left lungs of 6 cats were pump-perfused through the left pulmonary artery with blood withdrawn from the inferior vena cava. The animals were ventilated mechanically, and blood gases and pH were measured and maintained within normal limits. The pulmonary vascular resistance was calculated from measurements of pulmonary arterial pressure, left atrial pressure, and blood flow. Changes in pulmonary vascular resistance caused by 3% oxygen breathing, prostaglandin F2 alpha, angiotensin I, and angiotensin II were measured before and after captopril (20 mg/kg, i.v.). The pulmonary vascular response to hypoxia was not altered by the blockade of angiotensin II production. The responses to prostaglandin F2 alpha, and angiotensin II were unchanged as well, indicating that the vasoactivity of the pulmonary vessels was not altered. The response to angiotensin I was eliminated completely. These results indicate that angiotensin II is not necessary for, and does not alter, hypoxic pulmonary vasoconstriction in the cat.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6166801     DOI: 10.1097/00005344-198103000-00008

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  8 in total

1.  Effects of captopril in patients with chronic obstructive pulmonary disease and secondary pulmonary hypertension.

Authors:  D Patakas; D Georgopoulos; H Rodini; P Christaki
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401

2.  Effect of cyclic guanosine monophosphate on hypoxic and angiotensin-II-induced pulmonary vasoconstriction.

Authors:  K Fujimoto; A Sakai; S Yoshikawa; S Shinozaki; Y Matsuzawa; K Kubo; T Kobayashi; G Ueda; M Sekiguchi; N F Voelkel
Journal:  Lung       Date:  1990       Impact factor: 2.584

3.  Perindopril, an angiotensin converting enzyme inhibitor, in pulmonary hypertensive rats: comparative effects on pulmonary vascular structure and function.

Authors:  T K Jeffery; J C Wanstall
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

4.  Effects of captopril on pulmonary haemodynamics.

Authors:  C Richard; J L Ricome; A Rimailho; M Conrad; P Auzépy
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

Review 5.  Lung Circulation.

Authors:  Karthik Suresh; Larissa A Shimoda
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

6.  Haemodynamic and hormonal effects of captopril in primary pulmonary hypertension.

Authors:  H Ikram; A H Maslowski; M G Nicholls; E A Espiner; F T Hull
Journal:  Br Heart J       Date:  1982-12

Review 7.  Hypoxic pulmonary vasoconstriction.

Authors:  J T Sylvester; Larissa A Shimoda; Philip I Aaronson; Jeremy P T Ward
Journal:  Physiol Rev       Date:  2012-01       Impact factor: 46.500

8.  Endogenous angiotensin II in the regulation of hypoxic pulmonary vasoconstriction in anaesthetized dogs.

Authors:  Ives Hubloue; Benoît Rondelet; François Kerbaul; Dominique Biarent; Guiti Malekzadeh Milani; Michel Staroukine; Pierre Bergmann; Robert Naeije; Marc Leeman
Journal:  Crit Care       Date:  2004-05-14       Impact factor: 9.097

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.